JNJ-5207852

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameJNJ-5207852
Drug Alias NameJNJ-5207852
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor antagonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsCognition DisordersSleep Wake DisordersMemory Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsCognition DisordersSleep Wake DisordersMemory Disorders

Other Information

ATC CodeN/A
Related LinksN/A